End Brain Cancer Initiative adds Dr. Morana Vojnic to medical advisory board

The End Brain Cancer Initiative has named Dr. Morana Vojnic to its Medical Advisory Board as the Seattle-based nonprofit expands support for patients with primary and metastatic brain tumors. The move adds a neuro-oncology leader from Rutgers Cancer Institute and RWJBarnabas Health as the group builds out education and services for metastatic brain disease.

Why it matters: - Dr. Morana Vojnic brings neuro-oncology expertise in primary and metastatic brain tumors to a patient advocacy group focused on improving access, education and care. - The appointment comes as the End Brain Cancer Initiative says its patient caseload is increasing among patients with cancers that have spread to the brain. - The addition is meant to support education programs, services and research around metastatic brain disease.

What happened: - The End Brain Cancer Initiative announced that Dr. Morana Vojnic has joined its Medical Advisory Board. - Dr. Vojnic serves as Director of Neuro-Oncology at Rutgers Cancer Institute and System Leader for Neuro-Oncology at RWJBarnabas Health. - The announcement was made June 24, 2026, from Seattle.

The details: - Dr. Vojnic’s work centers on multidisciplinary clinical care, clinical trials and research for patients with primary and metastatic brain tumors. - Dellann Elliott Mydland, EBCI president and CEO, said Dr. Vojnic’s experience in metastatic brain tumors and precision oncology makes her a valuable addition to the board. - Mydland said Dr. Vojnic will help build out patient education programs and services for metastatic disease. - EBCI says it is a 501(c)(3) nonprofit patient advocacy organization focused on disease education, awareness, outreach, increasing patient access and improving standard of care. - The group says it was formerly known as the Chris Elliott Fund. - EBCI says it works to ensure patients with brain cancer, brain tumors or metastatic disease to the brain have equal access to advanced diagnostics, treatments, specialists and clinical trial participation. - The organization says it partners with industry, patients, researchers, advocacy groups, medical teams and hospital networks. - EBCI directs readers to learn more about the organization. - EBCI asks supporters to consider a $50 donation at the donation page.

Between the lines: - The appointment signals that EBCI is leaning further into metastatic brain cancer, not just primary brain tumors. - Adding a clinician tied to both Rutgers Cancer Institute and RWJBarnabas Health may help the nonprofit strengthen its medical credibility and expand practical education for patients and caregivers. - Dr. Vojnic said advocacy helps advance research, improve access to care and keep patients and caregivers at the center of the work.

What's next: - EBCI says Dr. Vojnic will become instrumental in developing metastasized disease education programs and services. - The organization says it will continue working to improve patient education, access, outcomes and research in metastatic brain disease. - EBCI also plans to keep supporting patients and families through advocacy, education and support programs.

The bottom line: - EBCI is adding a brain tumor specialist as demand grows, aiming to deepen its reach with patients facing metastatic disease to the brain.